发明名称 |
BILAYERED COMPOSITE TABLET FORMULATION COMPRISING ATORVASTATIN, IRBESARTAN AND MAGNESIUM CARBONATE |
摘要 |
Disclosed are a bilayered composite tablet formation comprising (a) a first layer comprising irbesartan or a pharmaceutically acceptable salt thereof; and (b) a second layer comprising atorvastatin or a pharmaceutically acceptable salt thereof and magnesium carbonate (MgCO3) in a weight ratio of 1:4 to 1:5, and a method for preparing the same. Exhibiting excellent dissolution rates and bioavailability, the bilayered composite tablet formulation is useful as a therapeutic for hypertension and hypercholesterolemia. |
申请公布号 |
US2015209290(A1) |
申请公布日期 |
2015.07.30 |
申请号 |
US201314421467 |
申请日期 |
2013.08.30 |
申请人 |
HANMI PHARM. CO., LTD |
发明人 |
Kim Yong Il;Cho Jung Hyun;Choi Jun Young;Choi Young Keun;Park Jae Hyun;Woo Jong Soo |
分类号 |
A61K9/20;A61K31/40;A61K9/24;A61K31/4184 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
1. A bilayered composite tablet formulation, comprising:
(a) a first layer comprising irbesartan or a pharmaceutically acceptable salt thereof; and (b) a second layer comprising atorvastatin or a pharmaceutically acceptable salt thereof and magnesium carbonate in a weight ratio of 1:4 to 1:5. |
地址 |
Hwaseong-si, Gyeonggi-do KR |